The release of those numbers comes just days after a watershed federal policy change: beginning July 1, 2026, eligible Medicare Part D beneficiaries can access GLP-1 medications approved for weight loss including Wegovy, oral Wegovy, Zepbound, and Foundayo for a flat $50 monthly copay through a new program called the Medicare GLP-1 Bridge
Gallbladder issues: Pain in the upper right abdomen, fever, nausea, or yellowing of the skin or eyes may point to gallstones or gallbladder inflammation
Ferrando-Martinez S, Ruiz-Mateos E, Hernandez A, Gutierrez E, Rodriguez-Mendez Mdel M, Ordonez A, et al
According to the FDA label, the inactive ingredients include sodium chloride, sodium phosphate dibasic heptahydrate, sodium hydroxide and/or hydrochloric acid (for pH adjustment), and water for injection